Belgium
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
99.76 |
Jan. 14, 2025 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
70.61 |
Jan. 14, 2025 | USD 150.68 | -0.48% |
|
Belgium |
|
3 |
23.89 |
Jan. 14, 2025 | USD 19.13 | -0.63% |
|
Belgium |
|
4 |
10.06 |
Jan. 14, 2025 | USD 19.81 | 0.71% |
|
Belgium |
|
5 |
7.21 |
Jan. 14, 2025 | USD 24.20 | -0.41% |
|
Belgium |
|
6 |
-5.50 |
Jan. 14, 2025 | USD 3.28 | -5.91% |
|
Belgium |
|
7 |
-40.02 |
Jan. 14, 2025 | USD 13.71 | -0.44% |
|
Belgium |
The Biotechnology company in Belgium with the highest Price to Earnings Ratio (P/E) is UCB SA (Brussels Stock Exchange: UCB.BR) at 99.76.
The Biotechnology company in Belgium with the lowest Price to Earnings Ratio (P/E) is Ion Beam Applications SA (Brussels Stock Exchange: IBAB.BR) at -40.02.
The top 10 Biotechnology companies in Belgium by Price to Earnings Ratio (P/E) are UCB SA, Financière de Tubize SA, Azelis Group NV, Tessenderlo Group NV, Galapagos NV, Biotalys NV and Ion Beam Applications SA.
The bottom 10 Biotechnology companies in Belgium by Price to Earnings Ratio (P/E) are Ion Beam Applications SA, Biotalys NV, Galapagos NV, Tessenderlo Group NV, Azelis Group NV, Financière de Tubize SA and UCB SA.